BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
10,077,000
9,823,000
9,048,000
8,386,000
7,477,000
Cost of Revenue
2,890,000
2,813,000
2,593,000
2,424,000
2,173,000
Gross Profit
7,187,000
7,010,000
6,455,000
5,962,000
5,304,000
Operating Expenses
Research Development
1,136,000
1,113,000
997,000
920,000
876,000
Selling General and Administrative
3,660,000
3,569,000
3,294,000
3,099,000
2,873,000
Total Operating Expenses
5,495,000
5,351,000
4,924,000
4,643,000
4,314,000
Operating Income or Loss
1,692,000
1,659,000
1,531,000
1,319,000
990,000
Interest Expense
320,000
241,000
229,000
233,000
284,000
Total Other Income/Expenses Net
-42,000
3,000
-370,000
-909,000
-1,356,000
Income Before Tax
1,354,000
1,422,000
933,000
177,000
-650,000
Income Tax Expense
-42,000
-249,000
828,000
-170,000
-411,000
Income from Continuing Operations
1,396,000
1,671,000
105,000
347,000
-239,000
Net Income
1,396,000
1,671,000
104,000
347,000
-239,000
Net Income available to common shareholders
1,396,000
1,671,000
104,000
347,000
-239,000
Reported EPS
Basic
-
1.21
0.08
0.26
-0.18
Diluted
-
1.19
0.08
0.25
-0.18
Weighted average shares outstanding
Basic
-
1,381,000
1,370,100
1,357,600
1,341,200
Diluted
-
1,401,400
1,392,700
1,377,200
1,341,200
EBITDA
-
2,262,000
1,727,000
955,000
129,000